Change Location × Madrid

    Recent Locations

      World Congress and Exhibition on Pharmaceutics and Drug Delivery in Madrid


      • World Congress and Exhibition on Pharmaceutics and Drug Delivery Photo #1
      1 of 1
      October 21, 2019

      Monday   8:00 AM - 5:00 PM

      El lugar se confirmará la semana del 24 de Septiembre
      Madrid, Spain

      Performers:
      • No Performers Listed
      EVENT DETAILS
      World Congress and Exhibition on Pharmaceutics and Drug Delivery

      World Congress and Exhibition on Pharmaceutics and Drug Delivery
      About this Event
      About

      PULSUS takes immense pleasure in inviting all the participants from across the globe to attend “World Congress and Exhibition on Pharmaceutics and Drug Delivery during October 21-22, 2019 at London, UK. This comprises of proficient keynote presentations, verbal speeches, productive poster presentations and exhibitions providing insights into the importance and efficiency of pharma field.

      Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity. With a legacy of 30 years of excellence in Medical Publishing, Now, we are running several International Conferences in the fields of Medical, Clinical, Life Science and, Pharma.

      Pharmaceutics 2019 Conference highlights the theme “Advancing the Research Trends in Pharmaceutics and Drug Delivery Systems”. Pharmaceutics 2019 is an event intended to provide an exclusive platform for new researchers, scholars, students and educators to showcase their novel ideas and discuss the most recent innovations, trends and key concerns adopted in the field of pharma and drug delivery. The two days of the educational program will include keynote presentations, oral presentations, and poster presenters on the advanced techniques as well as papers in all the fields of pharma in health care. Pharmaceutics 2019 Conference aims to explore advances in pharma and drug delivery systems, management and education in relation to health disparities as well as a breadth of other topics. Pharmaceutics 2019 will provide an opportunity for pharma professionals and educators to exchange research evidence, models of best practice and innovative ideas. It is a platform for pharma students, faculty, deans, researchers, and leaders to collaborate on topics affecting the pharma field.

      Attendees can:

      Take advantage of opportunities to learn insights about Pharmaceutics and Drug Delivery from a variety of oral and poster presentations.

      Meet and network with pharma experts ranging from students to deans, faculty, and researchers.Take advantage of opportunities to collaborate with drug delivery experts from around the world.

      Attend prominent plenary sessions about relevant issues affecting Pharmaceutics and the recent techniques adapted in drug delivery.

      Who should attend?

      Pharmaceutical, biotech, CRO, diagnostic and academic professionals specializing in:

      Drug Delivery

      Large & Small Molecule Drug Discovery

      Molecular Biology

      Peptide Development and Optimization

      Protein Chemistry

      Therapeutics Peptide Chemistry

      Discovery Technology

      Specialty Delivery and Formulation Service Providers

      Why should attend?

      10+ Keynote Speaker Session

      50+ speaker faculty over 3 full days sharing innovative peptide

      Drug development take-home strategies

      5+ Workshops

      13 Interactive sessions

      Mixture of Industry and Academia Delegates

      Networking

      Exhibit hall with leading specialty manufacturing

      Instrumentation and development providers

      Track Categories

      The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

      Track 1 : Pre-Formulation & Formulation Aspects

      This track includes Pharmaceutical : Pre-Formulation and Formulation aspects which is the process in which different chemical substances i.e., active chemical substances will combined together to produce a medical compound i.e., medical drug. This process involves production of drug which characterized by two things: Stability of the product, second Acceptability to the patient. Formulation studies focuses on factors like particle size, polymorphism, pH and solubility, in order to check whether these factors will effect on bioavailability of the drug or not. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation and Medication Formulation.

      This track is representing Pharmaceutical Excipients Pharmaceutical Product Development ,Types of Drug Formulation ,Ophthalmic Formulation ,Pediatric Formulation Development, Medication Formulation ,Topical Formulations

      Pharmaceutical Formulations Market Size worth $ 8.24 Billion By 2021 | CAGR: 6.8%

      The global Pharmaceutical Formulations market is estimated to reach USD 8.24 Billion by 2021, growing at a CAGR of 6.8% during the forecast period

      Track 1-1 Preformulation in Drug Discovery

      Track 1-2 Preformulation in Drug Development

      Track 1-3 Drug Formulation Considerations

      Track 1-4 Major Challenges in Drug Development

      Track 1-5 Physiological Drug Environment

      Track 1-6 Freeze Drying

      Track 1-7 Hot Melt Extrusion

      Track 2 : Pharmacokinetics and Pharmacodynamics in Drugs

      This track will include the usage of Pharmacokinetics and Pharmacodynamics in Drugs. Pharmacology is basically the study of drugs. Pharmacodynamics is the effect that drugs have on the body. Pharmacokinetics is the effect the body has on the drugs. Pharmacokinetics includes absorption, distribution, metabolism and excretion of drugs.

      Few major topics of this session will be: Pharmacokinetic Parameters, Pharmacodynamic Parameters, Absorption of Drugs, Distribution of Drugs, Biotransformation/Metabolism, Excretion of Drugs, Pharmacodynamics

      Track 2-1 Pharmacokinetic Parameters

      Track 2-2 Pharmacodynamic Parameters

      Track 2-3 Absorption of Drugs

      Track 2-4 Distribution of Drugs

      Track 2-5 Biotransformation/Metabolism

      Track 2-6 Excretion of Drugs

      Track 2-7 Pharmacodynamics

      Track 3 : Drug Targeting and Design

      In this session we will talk about the main objective in drug design and drug targeting. Drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it. The remedial reaction of a drug relies on the cooperation of drug molecules with cell on cell membrane related biological events at receptor sites in concentration dependent manner.

      Few major tracks of this session will be: Drug Targeting strategies, Factors influencing Drug Targeting, Advances in Drug Targeting components, Recent Approaches to Drug Targeting, Rational Drug Design, Computer Aided Drug Design

      Track 3-1 Drug Targeting strategies

      Track 3-2 Factors influencing Drug Targeting

      Track 3-3 Advances in Drug Targeting components

      Track 3-4 Recent Approaches to Drug Targeting

      Track 3-5 Rational Drug Design

      Track 3-6 Computer Aided Drug Design

      Track 4 : Routes of Drug Delivery

      In this session we will talk about the route of administration in pharmacology and toxicology which is basically the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied.

      Few major tracks of this session will be: Oral Drug Delivery, Buccal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Parenteral Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Geriatric Drug Delivery, Pediatric Drug Delivery

      Track 4-1 Oral Drug Delivery

      Track 4-2 Buccal Drug Delivery

      Track 4-3 Nasal Drug Delivery

      Track 4-4 Ophthalmic Drug Delivery

      Track 4-5 Topical Drug Delivery

      Track 4-6 Pulmonary Drug Delivery

      Track 4-7 Parenteral Drug Delivery

      Track 4-8 Rectal Drug Delivery

      Track 4-9 Vaginal Drug Delivery

      Track 4-10Geriatric Drug Delivery

      Track 4-11Paediatric Drug Delivery

      Track 5 : Nanoparticulate Drug Delivery Systems

      This track will includes Nanoparticle technology which recently showed to hold a great promise for drug delivery applications in nanomedicine due to its beneficial properties, such as better encapsulation, bioavailability, control release, and lower toxic effect. Despite the great progress in nanomedicine, there remain many limitations for clinical applications on nanocarriers. Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.To overcome these limitations, advanced nanoparticles for drug delivery have been developed to enable the spatially and temporally controlled release of drugs in response to specific stimuli at disease sites. Furthermore, the controlled self-assembly of organic and inorganic materials may enable their use in theranostic applications. This review presents an overview of a recent advanced nanoparticulate system that can be used as a potential drug delivery carrier and focuses on the potential applications of nanoparticles in various biomedical fields for human health care. A novel process for synthesis of polymeric nanoparticles for use in drug delivery applicationsusing the electrospraying technique. The technologyis standardized for synthesis of natural polymer based nanoparticles such as chitosan-gelatin based nanoparticles.

      Track 5-1Liposomal Drug Delivery Systems

      Track 5-2Microemulsions and Nanoemulsions

      Track 5-3Solid Lipid Nano and Microparticles

      Track 5-4Organic Nanotubes: Promising Vehicles for Drug Delivery

      Track 5-5Dendrimers

      Track 5-6Micelles

      Track 5-7Cyclodextrins

      Track 5-8Polymers

      Track 5-9Nanogels

      Track 5-10Metal Nanoparticles and Quantum Dots

      Track 6 : Nanotechnology in Drug Delivery

      Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Using nanoparticle contrast agents, images such as ultrasound and MRI have a favorable distribution and improved contrast. This might be accomplished by self assembled biocompatible nanodevices that will detect, evaluate, treat and report to the clinical doctor automatically. Nanotechnology ("nanotech") is manipulation of matter on an atomic, molecular, and supramolecular scale. The earliest, widespread description of nanotechnology referred to the particular technological goal of precisely manipulating atoms and molecules for fabrication of macro scale products, also now referred to as molecular nanotechnology. A more generalized description of nanotechnology was subsequently established by the National Nanotechnology Initiative, which defines nanotechnology as the manipulation of matter with at least one dimension sized from 1 to 100 nanometers.

      Track 6-1Cosmetics

      Track 6-2Controlled Drug Delivery

      Track 6-3Transdermal Drug Delivery

      Track 6-4Dermal Drug Delivery

      Track 6-5Antimicrobial nanoemulsions

      Track 6-6Cancer therapy

      Track 6-7Treatment of other diseases

      Track 6-8Oral delivery of poorly soluble drugs

      Track 7 : Pharmaceutical Nanotechnology

      Nano pharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nano pharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the Nano scale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nano pharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via Nano pharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery and drug delivery. Nano pharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process.

      Track 7-1Pharmaceutical Nanotechnology based Systems

      Track 7-2Characterization of Pharmaceutical Nanotools

      Track 7-3Engineering of Pharmaceutical Nanosystems

      Track 7-4Applications of Pharmaceutical Nanotools

      Track 7-5Challenges to Pharmaceutical Nanotechnology

      Track 7-6Future Prospects of Pharmaceutical Nanotechnology

      Track 8 : Smart Drug Delivery Systems

      With Smart Drug Delivery Technology the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. To enhance their therapeutic effects and reduce the related side effects, active drug molecules should selectively accumulate in the disease area for a prolonged period with high controllability. Drug delivery refers to the approaches, formulations, technologies, and systems for transporting therapeutics in the body as needed to safely and efficiently achieve their desired therapeutic effects. Conventional drug delivery systems (DDSs) are often accompanied by systemic side effects that mainly attributable to their nonspecific bio-distribution and uncontrollable drug release characteristics. To overcome these limitations, advanced controlled DDSs have been developed to achieve the release of payloads at the target sites in a spatial controlled manner. In comparison to the conventional DDSs, the smart controlled DDSs can effectively reduce the dosage frequency, while maintaining the drug concentration in targeted organs/tissues for a longer period of time. In this sense, the controlled DDSs provide broad insights and fascinating properties for decreasing drug concentration fluctuation, reducing drug toxicities and improving therapeutic efficacy.

      Track 8-1Targeted Drug Delivery

      Track 8-2Brain Delivery

      Track 8-3Mucosal Drug Delivery

      Track 8-4Skin Drug Delivery

      Track 8-5Pulmonary Drug Delivery

      Track 8-6Cancer Delivery

      Track 8-7Insulin Delivery

      Track 8-8Self-Emulsifying Drug Delivery Systems (SEDDS)

      Track 8-92D and 3D Printing In Drug Delivery

      Track 8-10BioMEMS

      Track 8-11Blood Brain Barrier Delivery

      Track 8-12Antibody Targeted-Drug Conjugates

      Track 8-13Nucleic Acid Drug Delivery Systems

      Track 8-14Gene Delivery

      Track 9 : Biomaterials in Drug Delivery

      This track will includes Nanoparticle technology which recently showed to hold a great promise for drug delivery applications in nanomedicine due to its beneficial properties, such as better encapsulation, bioavailability, control release, and lower toxic effect. Despite the great progress in nanomedicine, there remain many limitations for clinical applications on nanocarriers. Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.To overcome these limitations, advanced nanoparticles for drug delivery have been developed to enable the spatially and temporally controlled release of drugs in response to specific stimuli at disease sites. Furthermore, the controlled self-assembly of organic and inorganic materials may enable their use in theranostic applications. This review presents an overview of a recent advanced nanoparticulate system that can be used as a potential drug delivery carrier and focuses on the potential applications of nanoparticles in various biomedical fields for human health care. A novel process for synthesis of polymeric nanoparticles for use in drug delivery applicationsusing the electrospraying technique. The technologyis standardized for synthesis of natural polymer based nanoparticles such as chitosan-gelatin based nanoparticles.

      Track 9-1Cells and Proteins

      Track 9-2Proteins and Surfaces

      Track 9-3Ceramics and Metals

      Track 9-4Polymers

      Track 9-5Wound Healing

      Track 9-6Translational Sciences

      Track 9-7Biomaterials Processing & Devices

      Track 9-83D Printing Technologies

      Track 9-9Biomaterials & Therapeutics

      Track 9-10Musculoskeletal

      Track 9-11Nanomaterials & Nanotechnologies

      Track 9-12Tissue Regeneration

      Track 10 : Vaccine Drug Delivery Systems

      Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulations of antigen into delivery systems that administer antigen in particulate form rather than solution form.

      Track 10-1Cancer vaccines

      Track 10-2Influenza vaccines/virus

      Track 10-3Novel vaccines

      Track 10-4Clinical trials

      Track 10-5Human vaccines

      Track 10-6HIV/AIDS vaccines

      Track 10-7HPV vaccines

      Track 10-8Therapeutic vaccination for auto immune diseases

      Track 10-9New vaccines

      Track 10-10Veterinary vaccines

      Track 10-11Computed Tomographic Scanning (CT Scanning)

      Track 10-12Magnetic Resonance Imaging

      Track 11 : Medical Devices for Drug Delivery

      Track 11-1Biomedical Instrumentation Measurements

      Track 11-2Measurement of Blood Flow and Cardiac Output

      Track 11-3Instrumentation for Psychophysiological Measurements

      Track 11-4Instrumentation for the Experimental Analysis of Behaviour

      Track 11-5Respiratory Therapy Equipment

      Track 11-6Pacemakers and Defibrillators

      Track 11-7Quality by Design (QbD)

      Track 11-8Instrumentation for the Medical Use of Radioisotopes

      Track 11-9Ophthalmic and ENT Instruments

      Track 11-10Ultrasonography

      Track 11-11Positron-Emission Tomographic (PET) Scanning

      Track 12 : Peptides and Protein Drug Delivery

      Track 12-1Peptide Vector for Biologics Brain Delivery

      Track 12-2Protein Formulation & Aggregation

      Track 12-3Protein therapeutics

      Track 12-4Polymers for delivery of proteins

      Track 12-5Peptide therapeutics

      Track 12-6Peptide therapeutics

      Track 12-7Cell-penetrating and cell-targeting

      Track 13 : Global Drug Delivery Policy

      Track 14 : Entrepreneurs Investment Meet

      Cost: $999 – $3,700

      Categories: Conferences & Tradeshows

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.